Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".

Preston, Ioana R; Roberts, Kari E; Miller, Dave P; Sen, Ginny P; Selej, Mona; Benton, Wade W; Hill, Nicholas S; Farber, Harrison W

Preston, Ioana R; Roberts, Kari E; Miller, Dave P; Sen, Ginny P; Selej, Mona; Benton, Wade W; Hill, Nicholas S; Farber, Harrison W.

Afiliação

Preston IR; Tufts University School of Medicine Boston, MA.
Roberts KE; Tufts University School of Medicine Boston, MA.
Miller DP; ICON Clinical Research San Francisco, CA.
Sen GP; ICON Clinical Research San Francisco, CA.
Selej M; Actelion Pharmaceuticals US Inc South San Francisco, CA.
Benton WW; Actelion Pharmaceuticals US Inc South San Francisco, CA.
Hill NS; Tufts University School of Medicine Boston, MA.
Farber HW; Boston University School of Medicine Boston, MA.

Circulation ; 133(20): e662, 2016 May 17.

Article em En | MEDLINE | ID: mdl-27185031

Assuntos

Hipertensão Pulmonar Primária Familiar; Varfarina; Gerenciamento Clínico; Humanos; Hipertensão Pulmonar; Sistema de Registros; Taxa de Sobrevida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Varfarina / Hipertensão Pulmonar Primária Familiar Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google